Clinical Trial Update: Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating autologous bone marrow-derived mesenchymal stromal cells in chronic kidney disease has completed; results are not provided in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stromal cells (BM-MSCs) (mesenchymal stromal cells)

Snippet

Sponsor: Royan Institute | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED